Developing next gen therapeutics for inflammatory diseases

 
edited.jpg

Dianomi Therapeutics is a development stage biopharmaceutical company advancing a pipeline of next generation treatments for inflammatory diseases, targeting osteoarthritis and pain. Our proprietary Mineral Coated Microparticle (MCM) technology is designed to provide proven drugs with sustained release delivery for improved stability, safety and efficacy.